A Phase 2/3 interventional study of Intradiscal Gelified Ethanol (Discogel) in Pain, Cervical and Discogenic Pain, sponsored by Gelscom SAS. Not yet recruiting at 2 sites in Italy. Open to participants aged 18 Years to 120 Years. Per ClinicalTrials.gov, last updated 2025-03-11.
Sponsored by Gelscom SAS · Phase 2/3, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 18 studies in Neck Pain with a site in Italy — 5 open to participants now, 5 under way, 2 of them phase 3. Neck Pain · Italy.
Among the 18 studies in Neck Pain with a site in Italy, this one is the 10th largest by planned enrollment of the 16 interventional ones that give a count, is one of 3 that started in 2025, is the only one in phase 2/3, and was the 13th registered.
1,367 studies on the registry are indexed under Neck Pain; 301 are open to participants now.
Browse Neck Pain studies →5 of the 18 studies in Neck Pain with a site in Italy are open now. Recruiting first, the newest first:
Aurel Mengri · Sites in Italy
Ages 18–75
Fondazione Don Carlo Gnocchi Onlus · Sites in Italy
Ages 18+
IRCCS San Raffaele · Sites in Italy
Ages 18–70 · Healthy volunteers
Humanitas Clinical and Research Center · Sites in Italy
Ages 18–99
A study can be open while its sites in Italy have not opened yet or have stopped. Only those recruiting at a site in Italy →
Of the 158 Neck Pain studies recruiting now, 25 (16%) set no upper age limit and 120 (76%) stop at 75 or younger; 8 take children under 18; 27 take healthy volunteers.
This study: 18 Years to 120 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
18 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 2 · Phase 2 2 · Phase 3 4 · Phase 4 1
First in 2005; this study’s year is marked. 3 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 60 is above the median of 50 across 1,122 interventional studies indexed under Neck Pain.
Median enrollment 70 across the 16 interventional studies, 123 across the 2 observational. Of the 10 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
2 of 18 have an industry lead sponsor. The 10 most frequent:
Gelscom SAS is the lead sponsor of 2 studies on the registry; 2 are open to participants now.
Gelscom SAS has 1 study filed under Neck Pain — fewer than ten, so there is no comparison to draw.
1 of the studies in Neck Pain with a site in Italy that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07832929Aurel MengriGelified Radiopaque Ethanol (Absolute Gel) in Cervical Disc Herniation: an Observational Study in Routine Clinical Practice (GENESIS) | 2026-11-23 |
Add it to your calendar (.ics) → With an account.
Among the 18 studies in Neck Pain with a site in Italy, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
The purpose of this study is to assesse safety and efficacy of the Intradiscal Gelified Ethanol for treatment in refractory cervical discogenic pain.
After being informed about the study and potential tisks, all patients giving written informed consent will undergo a inclusion visit (CT scan and X ray at least) for study entry. At Day 0, operation with Intradiscal Gelified Ethanol will be performed by the investigator. Follow visit will be performed at 3 months and 12 months
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Relapsed: the illness came back after treatment had worked. Refractory: it did not respond to treatment, or stopped responding while still on it.
The study doctor’s estimate of how long someone is likely to live. Criteria use it so that people can stay in the study long enough for it to answer its question.
Relapsed and refractory
Relapsed: the illness came back after treatment had worked. Refractory: it did not respond to treatment, or stopped responding while still on it.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Life expectancy
The study doctor’s estimate of how long someone is likely to live. Criteria use it so that people can stay in the study long enough for it to answer its question.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Patients who come with symptomatic cervical disc herniation or with cervical discogenic pain and meet the eligibility criteria.
Device: Intradiscal Gelified Ethanol (Discogel)
Intradiscal percutaneous injection of an intradiscal Gelified Ethanol
the mean change in pain intensity assessed by a verbal local rating scale (pain intensity numerical scale) between the pre-treatment measurement (inclusion visi) and the post-treatment measurement (Visit 2 at the 3 months)
In a 11-point numeric scale, 0 represents "NO PAIN" and 10 represents "EXTREME PAIN" (e.g., "pain as bad as you can imagine" and "worst pain imaginable").
Time frame: 3 months
Change in pain cervical intensity using the verbal local rating scale [
Scores range from 0-10. In a 11-point numeric scale, 0 represents "NO PAIN" and 10 represents "EXTREME PAIN" (e.g., "pain as bad as you can imagine" and "worst pain imaginable").
Time frame: 12 months
Change of consumption of painkillers
Number, frequency and dosage of pain relief treatments will be combine todescribe the difference in painkiller consumption before and after the operation
Time frame: 12 months
Incidence of complication and adverse event rates
Incidence of adverse event during 12 months after the treatment
Time frame: 12 months
Change in ability to manage everyday-life activity (Neck Disability Index (NDI) scale) [Time Frame : inclusion, 3 and 12 months after treatment].
The Neck Disability Index (NDI) is used to measure pain-related disability associated with activities of daily living in people with neck pain (index between 0 and 50). The original report provided scoring intervals for interpretation, as follows: 0 - 4 = no disability, 5 - 14 = mild, 15 - 24 = moderate, 25 - 34 = severe, above 34 = complete. The NDI contains 10 items-7 related to activities of daily living, 2 related to pain, and 1 related to concentration.
Time frame: 12 months
Subjective evaluation MacNab
The MacNab's scale is layered into 4 levels (excellent, good, fair and poor) according to the patient's well-being after surgery or procedure.The scores were divided into the following four grades: 75-100% (excellent), 50-74% (good), 25-49% (fair) and 0-24% (poor). "Excellent" is defined as "No pain; no restriction of activity". "Good" is defined as "Occasional pain of sufficient severity to interfere with the patient's ability to do his normal work or his capacity to enjoy himself in leisure hours".
Time frame: 12 months after treatment
Plan to share: No — Confidential data (Pre-market Study trial)
No publications or documents are linked to this record.
Start is estimated for Apr 2025; primary completion for Jul 2025, 3 months later.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Mar 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Gelscom SAS